Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.24 USD | -8.47% |
|
-23.79% | -53.26% |
06-20 | Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies | CI |
05-07 | Transcript : Cryoport, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Business Summary
Number of employees: 1,100
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharma/Pharma
82.6
%
| 194 | 81.7 % | 193 | 82.6 % | -0.67% |
Animal Health
13.0
%
| 33 | 14.1 % | 30 | 13.0 % | -9.22% |
Human Reproductive Medicine
4.4
%
| 10 | 4.2 % | 10 | 4.4 % | +3.62% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Americas
54.5
%
| 128 | 54.0 % | 127 | 54.5 % | -0.78% |
Europe, Middle East and Africa
26.1
%
| 42 | 17.8 % | 61 | 26.1 % | +44.43% |
Asia Pacific
19.4
%
| 67 | 28.2 % | 45 | 19.4 % | -32.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jerrell Shelton
CEO | Chief Executive Officer | 76 | 21/10/12 |
Director of Finance/CFO | 59 | 26/06/11 | |
Mark Sawicki
CTO | Chief Tech/Sci/R&D Officer | - | - |
Edward Zecchini
CTO | Chief Tech/Sci/R&D Officer | 63 | 12/09/13 |
Thomas Heinzen
IRC | Investor Relations Contact | - | 30/09/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Berman
BRD | Director/Board Member | 81 | 31/12/14 |
Linda Baddour
BRD | Director/Board Member | 65 | 14/03/21 |
Jerrell Shelton
CEO | Chief Executive Officer | 76 | 21/10/12 |
Edward Zecchini
CTO | Chief Tech/Sci/R&D Officer | 63 | 12/09/13 |
Director/Board Member | 65 | 24/09/15 | |
Director/Board Member | 59 | 15/06/14 | |
Ram M. Jagannath
BRD | Director/Board Member | 45 | 30/09/20 |
Daniel Hancock
BRD | Director/Board Member | 72 | 06/01/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 200,000 | 0 | 0 | 97.44 % |
Stock B | 1 | 49,257,444 | 47,997,182 ( 97.44 %) | 0 |
Company contact information
![address Cryoport, Inc.(CYRX)](https://cdn.zonebourse.com/static/address/23132732.png)
Group companies
Name | Category and Sector |
---|---|
Cryoport Netherlands BV
|
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.26% | 357M | |
-14.31% | 6.42B | |
+52.26% | 6.31B | |
+1.76% | 3.5B | |
+21.41% | 2.45B | |
+5.06% | 965M | |
+2.96% | 629M | |
-12.96% | 430M | |
-45.17% | 433M | |
+7.92% | 348M |
- Stock Market
- Equities
- CYRX Stock
- Company Cryoport, Inc.